+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Echinocandin B Market - Global Forecast to 2030- Product Image
Echinocandin B Market - Global Forecast to 2030- Product Image
Sale

Echinocandin B Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6127612
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The echinocandin B market is witnessing dynamic shifts as novel formulations, improved delivery mechanisms, and global regulatory changes drive new growth pathways. Senior executives require clear, actionable insights into evolving clinical needs, operational challenges, and international market changes shaping this critical antifungal space.

Market Snapshot: Echinocandin B Market Overview

The echinocandin B market represents a pivotal segment within antifungal therapies, defined by an expanding demand for safer and more robust treatment options targeting invasive fungal infections. The sector is propelled by continuous innovation in molecular design, patient-centric product improvements, and alliance-building across biopharmaceutical supply chains. Key drivers include rising incidence of fungal infections among immunocompromised populations, growing resistance to traditional antifungals, and the introduction of semi-synthetic echinocandin derivatives with advanced stability and pharmacokinetics. Market stakeholders span pharmaceuticals, specialty clinics, contract manufacturers, and healthcare delivery systems. Evolving international tariffs and localized regulatory pressures further impact pricing and access across major global regions, necessitating agile strategies to maintain clinical and operational resilience.

Scope & Segmentation: Echinocandin B Market Coverage

This report delivers detailed segmentation analysis and forecasts, enabling business leaders to identify and prioritize opportunity areas within the echinocandin B market. Main segmentation dimensions include:

  • Product Types: Anidulafungin, Caspofungin, Micafungin (both branded and generic options)
  • Therapeutic Applications: Esophageal candidiasis, invasive aspergillosis, invasive candidiasis
  • End Users: Hospitals, ambulatory care centers, specialty clinics
  • Distribution Channels: Hospital pharmacy (direct and third-party tender), online pharmacy, retail pharmacy
  • Route of Administration: Intravenous (continuous and intermittent infusion)
  • Formulations: Lyophilized powder (manual and ready-to-reconstitute), prefilled syringes
  • Dosage Regimens: Once or twice daily, offered in high or standard doses
  • Packaging Options: Multi-dose and single-dose packaging
  • Regional Analysis: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including key Western and emerging markets), Asia-Pacific (notably China, India, and Southeast Asia)
  • Key Companies: Coverage includes Merck & Co., Inc.; Astellas Pharma Inc.; Pfizer Inc.; Cipla Limited; Teva Pharmaceutical Industries Ltd.; Dr. Reddy's Laboratories Limited; Jiangsu Hengrui Medicine Co., Ltd.; Zhejiang Medicine Co., Ltd.; ScinoPharm (Qingdao) Co., Ltd.; and Shanghai Kehua Bio-Engineering Co., Ltd.

Key Takeaways for Decision-Makers

  • Innovation in echinocandin B derivatives is advancing tissue penetration, administration convenience, and patient safety, meeting unmet needs in invasive fungal infection management.
  • Strategic partnerships and licensing deals are consolidating research, development, and supply chain capabilities, especially amid growing regulatory scrutiny and expedited antifungal approval pathways.
  • Formulation advances, such as ready-to-reconstitute powders and prefilled syringes, optimize pharmacy workflows and minimize preparation errors in diverse clinical settings.
  • Integrated care models are shifting the therapeutic focus from monotherapy toward combination treatments and rapid pathogen identification, enabling more individualized clinical approaches.
  • Global market participants are adapting sourcing, procurement, and pricing strategies to navigate complex regional regulatory differences and shifting tariff policies.

Tariff Impact: U.S. 2025 Regulatory Change

Revised U.S. tariff schedules for 2025 will influence the cost and accessibility of echinocandin B, affecting active pharmaceutical ingredient imports. Pharmaceutical firms are mitigating these risks by diversifying supplier networks, renegotiating existing contracts, and forming domestic production partnerships. Healthcare systems are also working with regulators to explore potential tariff exemptions and rebate structures in response to budgetary constraints within hospital and outpatient formularies.

Methodology & Data Sources

The report draws on a rigorous combination of secondary research—including peer-reviewed literature, regulatory filings, and patent reviews—and targeted primary interviews with infectious disease specialists, procurement professionals, and supply chain experts. Data synthesis is supported by industry reports and verified against anonymized sales and distribution data. Robust quality assurance and peer review frameworks ensure objectivity and actionable insight.

Why This Report Matters

  • Delivers a comprehensive understanding of the echinocandin B market’s segmentation, technology trends, and regional adoption patterns to facilitate data-driven strategic decisions.
  • Informs procurement, clinical leadership, and R&D departments of emerging product shifts and regulatory changes with direct implications for market access and competitive positioning.
  • Empowers executives to anticipate risk, identify innovation catalysts, and adapt to evolving regulatory and economic constraints across critical geographies.

Conclusion

Integrating advanced molecular design, targeted collaborations, and proactive supply strategies positions industry leaders to capitalize on sustained echinocandin B growth. Adapting to regulatory and market dynamics will be essential to maximizing value and patient outcomes in this evolving therapeutic area.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advances in genetic engineering of Aspergillus nidulans for enhanced Echinocandin B biosynthesis
5.2. Emergence of novel semisynthetic derivatives of Echinocandin B targeting resistant Candida auris strains
5.3. Scale-up strategies for cost-efficient fermentation of Echinocandin B using optimized bioreactors and feedstocks
5.4. Regulatory harmonization efforts facilitating global approval of Echinocandin B as first-line antifungal therapy
5.5. Strategic partnerships between biotech startups and generics companies for Echinocandin B formulation innovation
5.6. Integration of artificial intelligence in strain selection and fermentation optimization for Echinocandin B production
5.7. Development of oral Echinocandin B prodrugs to address limitations of intravenous administration
5.8. Growing demand for Echinocandin B biosimilars amid rising antifungal resistance and healthcare budget constraints
5.9. Environmental impact assessments driving sustainable manufacturing practices in Echinocandin B production facilities
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Echinocandin B Market, by Product Type
8.1. Introduction
8.2. Anidulafungin
8.2.1. Branded
8.2.2. Generic
8.3. Caspofungin
8.3.1. Branded
8.3.2. Generic
8.4. Micafungin
8.4.1. Branded
8.4.2. Generic
9. Echinocandin B Market, by Application
9.1. Introduction
9.2. Esophageal Candidiasis
9.3. Invasive Aspergillosis
9.4. Invasive Candidiasis
10. Echinocandin B Market, by End User
10.1. Introduction
10.2. Ambulatory Care Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Echinocandin B Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.2.1. Direct Tender
11.2.2. Third Party Tender
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Echinocandin B Market, by Route of Administration
12.1. Introduction
12.2. Intravenous
12.2.1. Continuous Infusion
12.2.2. Intermittent Infusion
13. Echinocandin B Market, by Formulation
13.1. Introduction
13.2. Lyophilized Powder
13.2.1. Manual Reconstitution
13.2.2. Ready to Reconstitute
13.3. Prefilled Syringe
14. Echinocandin B Market, by Dosage Regimen
14.1. Introduction
14.2. Once Daily
14.2.1. High Dose
14.2.2. Standard Dose
14.3. Twice Daily
14.3.1. High Dose
14.3.2. Standard Dose
15. Echinocandin B Market, by Packaging
15.1. Introduction
15.2. Multi Dose Packaging
15.3. Single Dose Packaging
16. Americas Echinocandin B Market
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. Argentina
17. Europe, Middle East & Africa Echinocandin B Market
17.1. Introduction
17.2. United Kingdom
17.3. Germany
17.4. France
17.5. Russia
17.6. Italy
17.7. Spain
17.8. United Arab Emirates
17.9. Saudi Arabia
17.10. South Africa
17.11. Denmark
17.12. Netherlands
17.13. Qatar
17.14. Finland
17.15. Sweden
17.16. Nigeria
17.17. Egypt
17.18. Turkey
17.19. Israel
17.20. Norway
17.21. Poland
17.22. Switzerland
18. Asia-Pacific Echinocandin B Market
18.1. Introduction
18.2. China
18.3. India
18.4. Japan
18.5. Australia
18.6. South Korea
18.7. Indonesia
18.8. Thailand
18.9. Philippines
18.10. Malaysia
18.11. Singapore
18.12. Vietnam
18.13. Taiwan
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Merck & Co., Inc.
19.3.2. Astellas Pharma Inc.
19.3.3. Pfizer Inc.
19.3.4. Cipla Limited
19.3.5. Teva Pharmaceutical Industries Ltd.
19.3.6. Dr. Reddy's Laboratories Limited
19.3.7. Jiangsu Hengrui Medicine Co., Ltd.
19.3.8. Zhejiang Medicine Co., Ltd.
19.3.9. ScinoPharm (Qingdao) Co., Ltd.
19.3.10. Shanghai Kehua Bio-Engineering Co., Ltd.
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. ECHINOCANDIN B MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ECHINOCANDIN B MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ECHINOCANDIN B MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ECHINOCANDIN B MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ECHINOCANDIN B MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ECHINOCANDIN B MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2024 VS 2030 (%)
FIGURE 20. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS ECHINOCANDIN B MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS ECHINOCANDIN B MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC ECHINOCANDIN B MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC ECHINOCANDIN B MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. ECHINOCANDIN B MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. ECHINOCANDIN B MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 31. ECHINOCANDIN B MARKET: RESEARCHAI
FIGURE 32. ECHINOCANDIN B MARKET: RESEARCHSTATISTICS
FIGURE 33. ECHINOCANDIN B MARKET: RESEARCHCONTACTS
FIGURE 34. ECHINOCANDIN B MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ECHINOCANDIN B MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ECHINOCANDIN B MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ECHINOCANDIN B MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ECHINOCANDIN B MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ECHINOCANDIN B MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ECHINOCANDIN B MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ECHINOCANDIN B MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ECHINOCANDIN B MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ECHINOCANDIN B MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ECHINOCANDIN B MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ECHINOCANDIN B MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ECHINOCANDIN B MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ECHINOCANDIN B MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ECHINOCANDIN B MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ECHINOCANDIN B MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ECHINOCANDIN B MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ECHINOCANDIN B MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ECHINOCANDIN B MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ECHINOCANDIN B MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ESOPHAGEAL CANDIDIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ESOPHAGEAL CANDIDIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INVASIVE ASPERGILLOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INVASIVE ASPERGILLOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INVASIVE CANDIDIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INVASIVE CANDIDIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ECHINOCANDIN B MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ECHINOCANDIN B MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ECHINOCANDIN B MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ECHINOCANDIN B MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ECHINOCANDIN B MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ECHINOCANDIN B MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ECHINOCANDIN B MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ECHINOCANDIN B MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DIRECT TENDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ECHINOCANDIN B MARKET SIZE, BY THIRD PARTY TENDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ECHINOCANDIN B MARKET SIZE, BY THIRD PARTY TENDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ECHINOCANDIN B MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ECHINOCANDIN B MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CONTINUOUS INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ECHINOCANDIN B MARKET SIZE, BY CONTINUOUS INFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INTERMITTENT INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INTERMITTENT INFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ECHINOCANDIN B MARKET SIZE, BY MANUAL RECONSTITUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ECHINOCANDIN B MARKET SIZE, BY MANUAL RECONSTITUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ECHINOCANDIN B MARKET SIZE, BY READY TO RECONSTITUTE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ECHINOCANDIN B MARKET SIZE, BY READY TO RECONSTITUTE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ECHINOCANDIN B MARKET SIZE, BY HIGH DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ECHINOCANDIN B MARKET SIZE, BY HIGH DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ECHINOCANDIN B MARKET SIZE, BY STANDARD DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ECHINOCANDIN B MARKET SIZE, BY STANDARD DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL ECHINOCANDIN B MARKET SIZE, BY HIGH DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL ECHINOCANDIN B MARKET SIZE, BY HIGH DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL ECHINOCANDIN B MARKET SIZE, BY STANDARD DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL ECHINOCANDIN B MARKET SIZE, BY STANDARD DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL ECHINOCANDIN B MARKET SIZE, BY MULTI DOSE PACKAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL ECHINOCANDIN B MARKET SIZE, BY MULTI DOSE PACKAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL ECHINOCANDIN B MARKET SIZE, BY SINGLE DOSE PACKAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL ECHINOCANDIN B MARKET SIZE, BY SINGLE DOSE PACKAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS ECHINOCANDIN B MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS ECHINOCANDIN B MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS ECHINOCANDIN B MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS ECHINOCANDIN B MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES ECHINOCANDIN B MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 179. CANADA ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. CANADA ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. CANADA ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN, 2018-2024 (USD MILLION)
TABLE 182. CANADA ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN, 2025-2030 (USD MILLION)
TABLE 183. CANADA ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN, 2018-2024 (USD MILLION)
TABLE 184. CANADA ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN, 2025-2030 (USD MILLION)
TABLE 185. CANADA ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN, 2018-2024 (USD MILLION)
TABLE 186. CANADA ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN, 2025-2030 (USD MILLION)
TABLE 187. CANADA ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. CANADA ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. CANADA ECHINOCANDIN B MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. CANADA ECHINOCANDIN B MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. CANADA ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. CANADA ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. CANADA ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 194. CANADA ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 195. CANADA ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. CANADA ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. CANADA ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 198. CANADA ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 199. CANADA ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 200. CANADA ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 201. CANADA ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 202. CANADA ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 203. CANADA ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 204. CANADA ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 205. CANADA ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2018-2024 (USD MILLION)
TABLE 206. CANADA ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2025-2030 (USD MILLION)
TABLE 207. CANADA ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2018-2024 (USD MILLION)
TABLE 208. CANADA ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2025-2030 (USD MILLION)
TABLE 209. CANADA ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 210. CANADA ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 211. MEXICO ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. MEXICO ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. MEXICO ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN, 2018-2024 (USD MILLION)
TABLE 214. MEXICO ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN, 2025-2030 (USD MILLION)
TABLE 215. MEXICO ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN, 2018-2024 (USD MILLION)
TABLE 216. MEXICO ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN, 2025-2030 (USD MILLION)
TABLE 217. MEXICO ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN, 2018-2024 (USD MILLION)
TABLE 218. MEXICO ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN, 2025-2030 (USD MILLION)
TABLE 219. MEXICO ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. MEXICO ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. MEXICO ECHINOCANDIN B MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. MEXICO ECHINOCANDIN B MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. MEXICO ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. MEXICO ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. MEXICO ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 226. MEXICO ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 227. MEXICO ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 228. MEXICO ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 229. MEXICO ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 230. MEXICO ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 231. MEXICO ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 232. MEXICO ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 233. MEXICO ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 234. MEXICO ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 235. MEXICO ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 236. MEXICO ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 237. MEXICO ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2018-2024 (USD MILLION)
TABLE 238. MEXICO ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2025-2030 (USD MILLION)
TABLE 239. MEXICO ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2018-2024 (USD MILLION)
TABLE 240. MEXICO ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2025-2030 (USD MILLION)
TABLE 241. MEXICO ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 242. MEXICO ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL ECHINOCANDIN B MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL ECHINOCANDIN B MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN, 2025-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN, 2018-2024 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 329. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 330. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2018-2024 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY DOSAGE REGIMEN, 2025-2030 (USD MILLION)
TABLE 333. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2018-2024 (USD MILLION)
TABLE 334. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY ONCE DAILY, 2025-2030 (USD MILLION)
TABLE 335. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2018-2024 (USD MILLION)
TABLE 336. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY TWICE DAILY, 2025-2030 (USD MILLION)
TABLE 337. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 338. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 339. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 340. EUROPE, MIDDLE EAST & AFRICA ECHINOCANDIN B MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 341. UNITED KINGDOM ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 342. UNITED KINGDOM ECHINOCANDIN B MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 343. UNITED KINGDOM ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN, 2018-2024 (USD MILLION)
TABLE 344. UNITED KINGDOM ECHINOCANDIN B MARKET SIZE, BY ANIDULAFUNGIN, 2025-2030 (USD MILLION)
TABLE 345. UNITED KINGDOM ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN, 2018-2024 (USD MILLION)
TABLE 346. UNITED KINGDOM ECHINOCANDIN B MARKET SIZE, BY CASPOFUNGIN, 2025-2030 (USD MILLION)
TABLE 347. UNITED KINGDOM ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN, 2018-2024 (USD MILLION)
TABLE 348. UNITED KINGDOM ECHINOCANDIN B MARKET SIZE, BY MICAFUNGIN, 2025-2030 (USD MILLION)
TABLE 349. UNITED KINGDOM ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 350. UNITED KINGDOM ECHINOCANDIN B MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 351. UNITED KINGDOM ECHINOCANDIN B MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 352. UNITED KINGDOM ECHINOCANDIN B MARKET SIZE,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Echinocandin B market report include:
  • Merck & Co., Inc.
  • Astellas Pharma Inc.
  • Pfizer Inc.
  • Cipla Limited
  • Teva Pharmaceutical Industries Ltd.
  • Dr. Reddy's Laboratories Limited
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Zhejiang Medicine Co., Ltd.
  • ScinoPharm (Qingdao) Co., Ltd.
  • Shanghai Kehua Bio-Engineering Co., Ltd.

Related Reports

Packaging Market Report 2025 - Product Image

Packaging Market Report 2025

  • Report
  • 200 Pages
  • Global
From
US Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

US Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 110 Pages
  • United States
From
North America Packaging Market with Focus on the US: Insights & Forecast with Potential Impact of COVID-19 (2024-2028) - Product Image

North America Packaging Market with Focus on the US: Insights & Forecast with Potential Impact of COVID-19 (2024-2028)

  • Report
  • 77 Pages
  • North America
From
Backing Roll Cleaner Market - Global Forecast to 2030 - Product Image

Backing Roll Cleaner Market - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Polixetonium Chloride Market - Global Forecast to 2030 - Product Image

Polixetonium Chloride Market - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.